AwesomeCapital
Search This Blog
Monday, October 8, 2018
JPMorgan Remains bullish on Dynavax (DVAX) Ahead of ESMO Meeting
JPMorgan analyst, Anupam Rama, reiterated an Overweight rating and $27.00 price target on Dynavax Technologies (NASDAQ: DVAX)
https://www.streetinsider.com/Analyst+Comments/JPMorgan+Remains+bullish+on+Dynavax+%28DVAX%29+Ahead+of+ESMO+Meeting/14683150.html
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.
Newer Post
Older Post
Home
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.